Since medication errors can have severe consequences, the development of methods to improve patient safety is becoming increasingly important. The aim of this evaluation was to identify frequent medication errors in oncology as well as characteristic correlations in the various error patterns. In addition, the implementation rate of the proposed pharmaceutical intervention was determined in order to assess the benefit of a clinical pharmacist in the field of oncology.
Methods
The evaluation was based on a data-set from a national documentation system for medication errors and interventions (DokuPIK) used by hospital pharmacists in the field of oncology from 2008 to 2019, namely 6684 reported cases in oncology, representing about 5% of all reports in DokuPIK.
Results
The most frequently reported errors were incorrect doses (22% of reported errors), followed by interactions (14%); in 10% of errors the prescription/documentation was incomplete/incorrect. The intervention suggested by the pharmacist was implemented in 97% of the cases. Based on the respective Anatomical Therapeutical Chemical Classification (ATC codes), drugs (or groups of drugs) were identified that were reported frequently in connection with medication errors, namely carboplatin and cyclophosphamide as anticancer drugs pantoprazole as non-anticancer drug.
Conclusion
Frequently occurring medication errors in the field of oncology were identified, facilitating the development of specific recommendations for action and prevention strategies. The implementation of an electronic prescription software is particularly recommended for the avoidance of dosage errors in chemotherapy.
AyalewMBTegegnHGAbdelaOA. Drug related hospital admissions; A systematic review of the recent literatures. Bull Emerg Trauma2019; 7: 339–346.
2.
AlexopoulouADourakisSPMantzoukisD, et al.Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med2008; 19: 505–510.
3.
LeendertseAJEgbertsACGStokerLJ, et al.Frequency of and risk factors for preventable medication-related hospital admissions in The Netherlands. Arch Intern Med2008; 168: 1890–1896.
4.
PatelKJKediaMSBajpaiD, et al.Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol2007; 7(8), https://doi.org/10.1186/1472-6904-7-8.
5.
PirmohamedMJamesSMeakinS, et al.Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ2004; 329: 15–19.
6.
van der HooftCSDielemanJPSiemensC, et al.Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf2008; 17: 365–71.
7.
SchurigAMBöhmeMJustK, et al.Adverse drug reactions and emergencies - the prevalence of suspected ADR in four emergency departments in Germany. Dtsch Arztebl Int2018; 115: 251–258.
8.
StangASWingertASHartlinL, et al.Adverse events related to emergency department care: a systematic review. PLoS One2013; 8: e74214.
FreiECanellosGP. Dose: a critical factor in cancer chemotherapy. Am J Med1980; 69: 585–594.
12.
TjokrowidjajaAHoveyELewisCR, et al.Let’s talk about cytotoxic chemotherapy dosing: unravelling adjustments and off-protocol prescribing. Med J Aust2018; 210: 65–66.
13.
GriggsJJManguPBTeminS, et al.Appropriate chemotherapy dosing for obese adult patients with cancer: American society of clinical oncology clinical practice guideline. J Clin Oncol2012; 30: 1553–1561.
14.
UmarRMApikoglu-RabusSYumukPF. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients. Int J Clin Pharm2020; 42: 652–661.
15.
NeussMNGilmoreRRBeldersonKM, et al.Updated American society of clinical oncology/oncology nursing society chemotherapy administration safety standards, including standards for pediatric oncology. J Oncol Pract2016; 12: 1262–1271.
16.
GoldspielBHoffmanJMGoodinS, et al.ASHP Guidelines on preventing medication errors with chemotherapy and biotherapy. Am J Health-Syst Pharm2015; 72: e6–e35.
17.
LangebrakeCIhbe-HeffingerALeichenbergK, et al.Nationwide evaluation of day-to-day clinical Pharmacists’ interventions in German hospitals. Pharmacotherapy2015; 35: 370–379.
18.
LangebrakeCHohmannCLeziusS, et al.Clinical pharmacists’ interventions across German hospitals: results from a repetitive cross-sectional study. Int J Clin Pharm2022; 44: 64–71.
19.
Ihbe-HeffingerALangebrakeCHohmannC, et al.Prospective survey-based study on the categorization quality of hospital pharmacists’ interventions using DokuPIK. Int J Clin Pharm2019; 41: 414–423.
20.
World Health Organisation, Collaboration Centre for Drug Statistics Methodology. ATC: Structure and principles. Retrieved from: https://www.whocc.no/atc/structure_and_principles/. 2019, February 15, accessed May 5, 2021.
SchiekSRanftDTruckenbrodC, et al.Antibiotics stewardship team recommendations - an analysis under routine conditions in a university hospital. Gesundheitswesen2022; 84: 503–509.
24.
SchwappachDWernliM. Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature. Eur J Cancer Care2010; 19: 285–292.
25.
WeingartSNZhangLSweeneyM, et al.Chemotherapy medication errors. Lancet Oncol2018; 19: e191–e199.
26.
ReinhardtHOttePEggletonAG, et al.Avoiding chemotherapy prescribing errors: analysis and innovative strategies. Cancer2019; 125: 1547–1557.
27.
ElsaidKAGarguiloSCollinsCM. Chemotherapy e-prescribing_ opportunities and challenges. Integr Pharm Res Pract2015; 4: 39–48.
28.
SmallMBarrettAPriceGM. The impact of computerized prescribing on error rate in a department of Oncology/Hematology. J Oncol Pharm Pract2008; 14: 181–187.
29.
ChenCSeidelKArmitageJO, et al.Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American society for blood and marrow transplantation. Biol Blood and Marrow Transplant1997; 3: 331–340. https://pubmed.ncbi.nlm.nih.gov/9502301/
30.
RinkeMLShoreADMorlockL, et al.Characteristics of pediatric chemotherapy medication errors in a national error reporting database. Cancer2007; 110: 186–195.
31.
FyhrAAkselssonR. Characteristics of medication errors with parenteral cytotoxic drugs. Eur J Cancer Care2012; 21: 606–613.
32.
ChunDSFasoAMussHB, et al.Oncology pharmacist-led medication reconciliation among cancer patients initiating chemotherapy. J Oncol Pharm Prac2019; 26: 1156–1163.
33.
HerledanCBaudouinALarbreV, et al.Clinical and economic impact of medication reconciliation in cancer patients: a systematic review. Support Care Cancer2020; 28: 3557–3569.
34.
LiekwegAWestfeldMBraunM, et al.Pharmaceutical care for patients with breast and ovarian cancer. Support Care Cancer2012; 20: 2669–2677.
35.
TanakaKHoriATachiT, et al.Impact of pharmacist counseling on reducing instances of adverse events that can affect the quality of life of chemotherapy outpatients with breast cancer. J Pharm Health Care Sci2018; 4: 9.
36.
VegaTGSierra-SanchezJFMartinez-BautistaMJ, et al.Medication reconciliation in oncological patients: a randomized clinical trial. J Manag Care Spec Pharm2016; 22: 734–740.
37.
VucurCWirtzDAWeinholdL, et al.Drug-related problems in head and neck cancer patients identified by repeated medication reviews on consecutive therapy cycles. J Oncol Pharm Prac2021; 27: 1439–1446.
38.
Hoppe-TichyTHorschtJSchöningT. Inadvertent intrathecal vincristine application – survey of the situation in Germany und suggestions for prevention. KPH2010; 31: 181–187.
MorrisonMCopeVMurrayM. The underreporting of medication errors: a retrospective and comparative root cause analysis in an acute mental health unit over a 3-year period. Int J Mental Health Nurs2018; 27: 1719–1728.
42.
ScottSHennemanE. Underreporting of medical errors. Medsurg Nurs2017; 26: 211–214.
